Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.
JHEP reports : innovation in hepatology
View this publicationJHEP reports : innovation in hepatology
View this publicationPloS one
View this publicationAmerican journal of clinical dermatology
View this publicationJournal of cancer research and clinical oncology
View this publicationJournal of clinical medicine
View this publicationCell death and differentiation
View this publicationNature chemical biology
View this publicationDNA repair
View this publicationAnnual review of immunology
View this publicationZeitschrift fur Gastroenterologie
View this publication